Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225468 · ClinicalTrials.gov registry record · NA
Safe Options for ACL Recovery
A NA study of Opioid Use and Anterior Cruciate Ligament Injuries, sponsored by Karen Derefinko, PhD.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT04225468 is a NA study of Opioid Use and Anterior Cruciate Ligament Injuries that has completed, run by Karen Derefinko, PhD. The registered enrollment target is 120 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04225468, a NA study of Opioid Use and Anterior Cruciate Ligament Injuries, has completed, sponsored by Karen Derefinko, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries. This intervention is specifically designed to be used with patients (or for patients under 18, the patient and caregiver) undergoing Anterior Cruciate Ligament (ACL) reconstruction, a painful surgery that is often followed by at least 7 days of opioid medication.
Conditions Studied
Interventions
- BEHAVIORAL ACL Opioid Exposure Reduction Program
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2022-06-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04225468
The ClinicalTrials.gov registry entry for NCT04225468 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Karen Derefinko, PhD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which ACL Opioid Exposure Reduction Program is the first listed.
NCT04225468 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04225468 about?
NCT04225468 is a clinical study titled "Safe Options for ACL Recovery". The purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries. This intervention is specifically designed to be used with patients (or for patients under 18, the patient and caregiver) undergo...
What is the current status of trial NCT04225468?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2020-02-12. Estimated completion is 2022-06-03.
What conditions does trial NCT04225468 study?
This clinical trial studies the following conditions: Opioid Use, Anterior Cruciate Ligament Injuries.
What interventions are being tested in trial NCT04225468?
The interventions under investigation include: ACL Opioid Exposure Reduction Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04225468?
This trial is sponsored by Karen Derefinko, PhD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04225468 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.